File Download
  Patent History
  • Application
    US 12/3282084 2011-10-26
  • Publication
    US 20120107317 2012-05-03

published patent: Use Of Cytoplasmic C-Myc For Regulating Immune Responses

TitleUse Of Cytoplasmic C-Myc For Regulating Immune Responses
Priority Date2011-10-26 US 12/3282084
2010-10-27 US 12/407276P
Inventors
Issue Date2-Nov-2012
Citation
US Published patent application 20120107317. Washington, DC: US Patent and Trademark Office (USPTO), 2012 How to Cite?
AbstractThe Subject Invention Provides Novel Uses Of Cytoplasmic C-Myc For Modulation Of Innate Immune Responses. The Invention Is Based, At Least In Part, On The Surprising Discovery That Cytoplasmic C-Myc, Instead Of Nuclear C-Myc, Modulates Pro-Inflammatory Immune Responses Via Its Role As A Positive Feedback Regulator. Specifically, The Subject Invention Provides Methods For Treatment Or Amelioration Of Inflammatory Diseases And/Or Immune Disorders Via Inhibition C-Myc Expression Or Its Activity. Also Provided Are Methods For The Development Of Therapeutic Agents For Treating Infection, Inflammation, Immune Diseases And Autoimmune Diseases.
Persistent Identifierhttp://hdl.handle.net/10722/173821

 

DC FieldValueLanguage
dc.date.accessioned2012-11-02T06:19:27Z-
dc.date.available2012-11-02T06:19:27Z-
dc.date.issued2012-11-02-
dc.identifier.citationUS Published patent application 20120107317. Washington, DC: US Patent and Trademark Office (USPTO), 2012en_HK
dc.identifier.urihttp://hdl.handle.net/10722/173821-
dc.description.abstractThe Subject Invention Provides Novel Uses Of Cytoplasmic C-Myc For Modulation Of Innate Immune Responses. The Invention Is Based, At Least In Part, On The Surprising Discovery That Cytoplasmic C-Myc, Instead Of Nuclear C-Myc, Modulates Pro-Inflammatory Immune Responses Via Its Role As A Positive Feedback Regulator. Specifically, The Subject Invention Provides Methods For Treatment Or Amelioration Of Inflammatory Diseases And/Or Immune Disorders Via Inhibition C-Myc Expression Or Its Activity. Also Provided Are Methods For The Development Of Therapeutic Agents For Treating Infection, Inflammation, Immune Diseases And Autoimmune Diseases.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleUse Of Cytoplasmic C-Myc For Regulating Immune Responsesen_HK
dc.typePatenten_US
dc.identifier.emailLau, ASY=asylau@hku.hk-
dc.identifier.emailLi, CB=jamesli@graduate.hku.hk-
dc.identifier.emailPONG, Chi Him=johnpong@hku.hk-
dc.identifier.authorityLau, ASY:rp00474-
dc.identifier.authorityLi, CB:rp00496-
dc.description.naturepublished_or_final_version-
dc.contributor.inventorLau, ASY-
dc.contributor.inventorLi, CB-
dc.contributor.inventorPong, Chi Him-
dc.contributor.inventorYim, Howard Chi Ho-
patents.identifier.applicationUS 12/3282084en_HK
patents.description.assigneeUniv Hong Kong [Cn]en_HK
patents.description.countryUnited States of Americaen_HK
patents.date.publication2012-05-03en_HK
patents.identifier.hkutechidPAED-2010-00365-1en_HK
patents.date.application2011-10-26en_HK
patents.date.priority2011-10-26 US 12/3282084en_HK
patents.date.priority2010-10-27 US 12/407276Pen_HK
patents.description.ccUSen_HK
patents.identifier.publicationUS 20120107317en_HK
patents.relation.familyUS 2012107317 (A1) 2012-05-03en_HK
patents.relation.familyWO 2012055170 (A1) 2012-05-03en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats